SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-061920
Filing Date
2017-12-01
Accepted
2017-12-01 16:06:50
Documents
2
Period of Report
2017-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv480506_8k.htm 8-K 20888
2 EXHIBIT 4.1 tv480506_ex4-1.htm EX-4.1 29084
  Complete submission text file 0001144204-17-061920.txt   51331
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 171234279
SIC: 2836 Biological Products, (No Diagnostic Substances)